
Loading, please wait...

Loading, please wait...

Pelvic ultrasonography plays a central role in evaluating complex adnexal masses in routine gynecological practice. Among rare epithelial neoplasms, ovarian Brenner tumors present distinct diagnostic dilemmas for radiologists and gynecologic oncologists worldwide. These uncommon tumors account for approximately one to two percent of all ovarian neoplasms. Most patients remain asymptomatic until routine pelvic examinations or imaging studies reveal an incidental pelvic mass. However, establishing an accurate preoperative diagnosis remains challenging because these lesions often mimic other solid ovarian neoplasms.
Recently, a comprehensive systematic review analyzed the clinical and sonographic features of ovarian Brenner tumors to clarify their imaging spectrum. Researchers evaluated multi-center evidence to identify specific morphological and vascular features that differentiate benign lesions from borderline or malignant variants. Understanding these sonographic nuances empowers clinicians to optimize surgical strategies. Consequently, practitioners can avoid unnecessary radical surgeries in younger patients while ensuring prompt oncological staging for suspicious cases.
Furthermore, refined sonographic assessment guides multidisciplinary decision-making across ambulatory gynecological clinics and tertiary referral centers.
Brenner tumors predominantly affect postmenopausal women, with the highest incidence occurring in the fifth and sixth decades of life. Nevertheless, clinicians occasionally detect these neoplasms in premenopausal women during workups for menstrual irregularities or pelvic pain. The vast majority of benign tumors are small, unilateral, and asymptomatic. Clinicians often discover them incidentally during routine sonographic screenings or unrelated pelvic surgeries. Conversely, borderline and malignant counterparts tend to develop at an older age and frequently reach larger dimensions before detection.
Patients harboring borderline or malignant lesions often present with symptomatic abdominal enlargement, palpable pelvic masses, or non-specific lower abdominal fullness. In addition, hormonal activity occasionally accompanies these tumors because stromal luteinization can produce estrogenic or androgenic manifestations. Consequently, patients may experience abnormal uterine bleeding, postmenopausal bleeding, or endometrial hyperplasia. Therefore, gynecologists must carefully correlate clinical presentations and endocrine findings when evaluating adnexal masses with solid components on ultrasound. Furthermore, abnormal tumor markers such as CA-125 occasionally suggest malignant transformation during clinical staging evaluations. Consequently, clinicians should maintain clinical suspicion for hormone-producing neoplasms whenever postmenopausal patients develop unexplained endometrial thickening.
Ultrasonographic evaluation serves as the frontline imaging modality for characterizing ovarian architecture and classifying tumor components. According to systematic review data, approximately seventy-eight percent of all Brenner tumors display a prominent solid component. However, tumor morphology differs significantly between histological subtypes. Benign Brenner tumors frequently manifest as well-circumscribed, solid, hypoechoic masses that strongly resemble ovarian fibromas or thecomas. These benign masses typically demonstrate clear acoustic shadowing and sharp margins that help define their borders.
In contrast, borderline and malignant tumors demonstrate solid components in ninety percent of cases, showing significantly altered structural architecture. These advanced variants often exhibit multilocular-solid or purely solid morphologies with irregular outlines and heterogeneous internal echogenicity. Furthermore, malignant lesions frequently develop papillary projections or vegetations protruding into fluid-filled cystic cavities. Cystic spaces within malignant tumors often contain thick septations, internal debris, and hemorrhagic components. As a result, recognizing these complex architectural patterns alerts sonographers to potential malignancy during routine scanning. Additionally, standardized morphological assessment using transvaginal scanning ensures precise visualization of subtle internal cystic components.
Color and power Doppler ultrasonography provide pivotal insights into tumor angiogenesis and biological aggressiveness. The systematic review highlighted striking vascular differences between benign and malignant variants. Benign Brenner tumors typically exhibit minimal or completely absent blood flow on subjective color Doppler scoring. Approximately seventy-one percent of benign lesions show subjective color scores of one or two, reflecting dense, poorly vascularized fibrous stroma. This avascular or hypovascular appearance aligns with their indolent clinical nature.
Conversely, borderline and malignant tumors demonstrate moderate to abundant vascularity in nearly seventy-six percent of cases. Malignant transformation stimulates intense neoangiogenesis, creating chaotic, branching vessel architectures within solid components and papillary projections. Doppler waveforms in malignant lesions frequently reveal low resistive index and high systolic peak velocities, indicative of abnormal arteriovenous shunting. Consequently, subjective color Doppler scoring acts as a powerful discriminatory parameter during adnexal mass characterization. Sonographers who identify abundant internal flow within solid ovarian masses should maintain high clinical suspicion for malignancy. Furthermore, spectral Doppler analysis confirms elevated systolic velocities in hypervascular malignant masses.
Acoustic shadowing and intratumoral calcifications represent characteristic hallmarks frequently encountered during the sonographic examination of Brenner tumors. Histopathologically, these neoplasms contain dense fibroblastic stroma surrounding nests of transitional epithelium, often accompanied by dystrophic calcification. On ultrasound, calcifications present as intensely hyperechoic foci within the solid tumor matrix. These calcific deposits often cast dense posterior acoustic shadows, obscuring deeper pelvic structures. Clinicians frequently observe widespread distribution of calcifications across both benign and malignant variants.
However, the specific pattern of calcification provides meaningful clinical clues. Benign tumors frequently exhibit extensive, coarse, or plaque-like central calcifications with prominent acoustic attenuation. This dense shadowing sometimes creates significant diagnostic confusion, mimicking heavily calcified subserosal leiomyomas or mature cystic teratomas. In borderline and malignant tumors, calcifications appear more punctate, scattered, or confined to irregular solid projections. Furthermore, malignant variants often combine calcifications with soft, friable solid elements that lack significant acoustic attenuation. Therefore, sonographers must systematically evaluate the relationship between calcifications and surrounding tissue architecture. Consequently, careful multiplanar sonographic scanning prevents misinterpreting isolated calcifications as benign fibrothecomas.
Preoperative discrimination between benign Brenner tumors and borderline or malignant subtypes directly dictates surgical planning and oncological outcomes. Because benign Brenner tumors behave indolently, conservative fertility-sparing surgery or simple laparoscopic unilateral salpingo-oophorectomy represents the standard therapeutic approach. In postmenopausal women with asymptomatic benign lesions, minimally invasive surgery minimizes surgical morbidity and shortens hospital recovery times. Conversely, misclassifying a benign mass as malignant may subject patients to unnecessary staging laparotomies and lymphadenectomies.
Conversely, recognizing features indicative of borderline or malignant histology ensures appropriate preoperative staging and multidisciplinary surgical consultation. Malignant Brenner tumors require comprehensive surgical staging, including total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and peritoneal washings. Intraoperative frozen section biopsy serves as a vital intermediate diagnostic tool when ultrasound findings appear indeterminate. Furthermore, structured reporting frameworks, such as the International Ovarian Tumor Analysis rules, significantly improve risk stratification in daily clinical practice. By integrating sonographic morphological patterns, Doppler flow assessments, and clinical parameters, gynecologists can effectively personalize operative strategies and safeguard patient outcomes.
Benign Brenner tumors typically present as small, well-circumscribed solid masses exhibiting minimal vascularity on Doppler imaging and prominent acoustic shadowing from coarse calcifications. In contrast, borderline and malignant Brenner tumors frequently show multilocular-solid architecture, irregular contours, and solid components in ninety percent of cases. Additionally, malignant variants demonstrate moderate to abundant internal blood flow on Doppler examination and may present with associated ascites or peritoneal fluid collections.
Brenner tumors frequently mimic other pelvic pathologies due to their dense fibrous stroma and varied architectural patterns. Benign variants closely resemble ovarian fibromas, thecomas, or peduncular uterine leiomyomas because all exhibit solid hypoechoic stroma with acoustic shadowing. Furthermore, when cystic spaces or extensive calcifications appear, sonographers may mistake them for teratomas or cystadenocarcinomas. Therefore, combining Doppler assessment with careful transvaginal acoustic evaluation is critical to improve diagnostic precision preoperatively.
Management depends upon sonographic risk categorization, menopausal status, and histological suspicion. For well-circumscribed, poorly vascularized benign masses in reproductive-age women, conservative ovarian cystectomy or unilateral salpingo-oophorectomy via laparoscopy remains preferred. Conversely, when ultrasound reveals irregular multilocular-solid masses with rich Doppler vascularity, surgeons plan complete oncological staging with frozen section analysis. This multidisciplinary protocol ensures organ preservation for benign disease while securing prompt radical resection for true malignant neoplasms.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review highlights the sonographic spectrum of ovarian Brenner tumors. While benign tumors are typically hypovascular solid masses with calcifications, borderline and malignant lesions more frequently display prominent solid components and abundant Doppler vascularity, guiding surgical decisions.
Today

The randomized EARLY-RESYNC trial reveals that early left bundle branch pacing combined with guideline-directed medical therapy significantly improves LVEF and reduces LV end-systolic volume compared to medical therapy alone in patients with complete LBBB and mildly reduced ejection fraction (36%-50%).
Today

Recent data from PGIMER reveals that young adults diagnosed with type 2 diabetes face an aggressive disease trajectory. They encounter severe cardiovascular and microvascular damage within five years, occurring at higher rates than in type 1 diabetes despite lower mean blood glucose levels.
Today

A clinical overview of resveratrol supplementation in mitigating exercise-induced muscle damage. This narrative review explores physiological mechanisms, reductions in soreness markers like creatine kinase, dosage strategies, and bioavailability enhancements for sports medicine and nutrition practitioners.
Today

A novel smartphone-assisted biosensor utilizing molecularly imprinted polymers and catalytic nanozymes offers antibody-free, enzyme-free urinary microalbumin testing, enabling rapid, low-cost point-of-care screening for early chronic kidney disease.
Today